Patients with HIV Diagnosed with Cancer Have Increased Mortality Rates Tops SPT Week in Review

5. Survival Benefit Demonstrated with Abemaciclib Among Women with Metastatic Disease
Eli Lilly has announced that interim data from a phase 3 shows proof of a survival benefit with their breast cancer drug abemaciclib (Verzenio) among women with metastatic disease, read more.
4. New PrEP Approach Reduces Number of Pills Needed
Health officials in San Francisco are promoting a new strategy for administering pre-exposure prophylaxis for those at risk of contracting HIV, read more.
3. Patients with Psoriasis May Be at Elevated Risk of Cancer
A recent meta-analysis showed that patients with psoriasis may be at an increased risk of cancer, read more.
2. Predictive AI Causes Privacy Concerns
A London-based artificial intelligence company has developed a system that can analyze a patient’s health records, such as blood tests, and predict acute kidney disease up to 48 hours before onset; however, the technique has caused privacy concerns, read more.
1.  Patients with HIV Diagnosed with Cancer Have Increased Mortality Rates
People living with HIV who are diagnosed with cancer have increased mortality rates compared with patients diagnosed with cancer who are not HIV positive, read more.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Top news of the week from Specialty Pharmacy Times.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Top news of the week from Specialty Pharmacy Times.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.